共 66 条
[1]
Schmoll H-J(1998)Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer J Clin Oncol 16 301-308
[2]
Büchele T(1992)Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate J Clin Oncol 10 896-903
[3]
Grothey A(1999)Where do we stand with 5-fluorouracil? Semin Oncol 26 589-605
[4]
Dempke W(1999)Survival impact of chemotherapy in patients with colorectal metastases confined to the liver: are-analysis of 1458 non-operable patients randomised in 22 trials and 4 meta-analyses. Meta-Analysis Group in Cancer Ann Oncol 10 1317-1320
[5]
Thirion P(1998)Oral fluoropyrimidines in the treatment of colorectal cancer Eur J Cancer 34 1509-1513
[6]
Wolmark N(1998)The oral fluorouracil prodrugs Oncology (Huntingt) 12 48-51
[7]
Haddad E(1998)Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue Eur J Cancer 34 1274-1281
[8]
Buyse M(2000)Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients Cancer Chemother Pharmacol 45 291-297
[9]
Piedbois P(2002)Capecitabine as first-line treatment in colorectal cancer. Pooled data from two large, phase III trials Eur J Cancer 38 15-20
[10]
Meropol NJ(2002)First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin Ann Oncol 13 566-575